Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Archives of Internal Medicine|October 1, 1981
Yersinia enterocolitica lung infectionR D Bigler, R R Atkins, E J Wing
Biochemical Pharmacology|December 14, 1993
Effect of lovastatin on cell surface expression of Fc receptors or CD14 antigen in human monocytesM Esfahani, R D Bigler, E Gressen
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
S152 (CD27). A modulating disulfide-linked T cell activation antigenR D Bigler, Y Bushkin, N Chiorazzi
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNAH R Hubbell, G D Gibson, R D Bigler
Journal of Immunopharmacology|January 1, 1984
Dissociative effects of a novel immunomodulating agent (CP-20, 961) on host defenses of miceE J Wing, S Boehmer
The American Journal of Pathology|November 1, 1996
Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndromeR D Bigler, C M Boselli, B Foley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosisR D Bigler, M Khoo, S Lund-Katz, et al.
Pageof 10